Table 4.
TG level (mg/dl) | Number (%) of Repeat-Measures That Contributed to Fracture vs Nonfracture | Full Model HR (95% CI)a |
||
---|---|---|---|---|
For Fracture Incidence 2 or More Y Later, Based on Baseline Fasting TG Level | Time-Varying Analyses: TG Level at Visit i and Fracture Risk 2–5 Y Later |
|||
Single TG Level | Mean TG Level of 2 Consecutive Measuresb | |||
<150 | 793 (73)/7776 (77) | 1 (reference) | 1 (reference) | 1 (reference) |
150–299 | 242 (22)/2067 (20) | 0.89 (0.48–1.65) | 1.13 (0.80–1.59) | 1.03 (0.70–1.52) |
≥300 | 49 (5)/298 (3) | 2.48 (1.13–5.44) | 1.94 (1.14–3.30) | 2.21 (1.29–3.79) |
Full model included age at baseline, race/ethnicity, study site, smoking, drinking, physical activity, menopausal stage (including exogenous hormone use), BMI, diabetes, and lumbar spine BMD.
Mean TG level for TG at visit i and the last TG level measured before visit i in relation to fractures between i + 2 and i + 5 y.